Expert Details Immunotherapy Developments in Lung Cancer – OncLive
OncLive |
Expert Details Immunotherapy Developments in Lung Cancer
OncLive “If there’s benefit in immunotherapy administration in the arm with [PD-L1] negative populations, even if the relative benefit is smaller, that may be a good rationale for use in those contexts if the patients who respond have durable responses—that … |
Science Magazine |
Disgraced surgeon is still publishing on stem cell therapies
Science Magazine Paolo Macchiarini, an Italian surgeon, has been fired from two institutions and faces the retraction of many of his papers after findings of scientific misconduct and ethical lapses in his research—yet this hasn’t prevented him from publishing again … |